Abstract
Post-transplant lymphoproliferative disorders (PTLDs) are a heterogeneous group of lymphoid neoplasms associated with immunosuppression following transplantation. Among PTLDs, monomorphic PTLD (m-PTLD) is the largest category; however, its characteristics and survival outcome are not fully understood because of low incidence. This study enrolled 30 adult patients with m-PTLD after kidney-transplantation (KT, n = 17) and hematopoietic stem cell transplantation (HSCT, n = 13) from January 1998 to December 2014. The incidence rates of m-PTLD were 0.74 and 3.63% in the KT and HSCT groups, respectively. M-PTLD patients in the HSCT group were younger and showed earlier onset, with EBV-encoded small RNAs (EBER) more frequently identified. Diffuse large B cell lymphoma (DLBCL) was the main pathological type, and the digestive system was the most extranodal involvement site in m-PTLD after KT and HSCT. Among the 28 patients with DLBCL m-PTLD,the complete remission rate after rituximab treatment was higher than in patients not administered rituximab treatment (P = 0.038). With a median follow-up of 46 months after m-PTLD diagnosis, the estimated 5-year overall survival (OS) was 59.2 ± 9.1% in all patients, and 64.2 ± 11.8 and 52.7 ± 14.1...Continue Reading
References
Nov 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T A ListerM Tubiana
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B D ChesonG P Canellos
Feb 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V LeblondV Levy
Feb 21, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Gerhard Opelz, Bernd Döhler
Jun 4, 2005·Blood·Pedro FarinhaRandy D Gascoyne
Jun 28, 2005·Critical Reviews in Oncology/hematology·Anna L TaylorJ Andrew Bradley
Sep 28, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Irene M GhobrialChristopher G McGregor
Nov 24, 2006·The American Journal of Surgical Pathology·Lawrence R JohnsonSteven H Swerdlow
Dec 19, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Danielle CanioniLuc Xerri
Apr 22, 2008·British Journal of Haematology·Matthew J HouriganMaher K Gandhi
Jul 2, 2008·International Urology and Nephrology·Vahid PourfarzianiBehzad Einollahi
Sep 3, 2009·Blood·Helen E Heslop
Jan 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew M EvensSonali M Smith
Jan 5, 2011·Pathology Oncology Research : POR·Gyula VégsoAnna Sebestyén
Dec 17, 2011·The Lancet Oncology·Ralf TrappeUNKNOWN European PTLD Network
Sep 6, 2012·Blood·King L TanRandy D Gascoyne
Feb 21, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sophie CaillardBruno Moulin
Feb 28, 2013·Leukemia & Lymphoma·Daan DierickxGregor Verhoef
Dec 6, 2014·Journal of Hematopathology·Christiane Stuhlmann-LaeiszWolfram Klapper
Citations
Jun 5, 2020·Pediatric Transplantation·Raphael C BosseWilliam B Slayton
Dec 21, 2018·BMJ Case Reports·Brianne J SullivanGabriel Sara
Jan 9, 2020·World Journal of Clinical Cases·Ze-Jia SunWei Wang
Jan 27, 2019·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Lukas Marcelis, Thomas Tousseyn
Jun 12, 2020·Therapeutic Advances in Hematology·Li LiuSizhou Feng